{"id":13034,"date":"2020-08-24T12:44:58","date_gmt":"2020-08-23T23:44:58","guid":{"rendered":"https:\/\/clladvocates.nz\/?p=13034"},"modified":"2020-08-24T12:44:58","modified_gmt":"2020-08-23T23:44:58","slug":"covid-19-severity-in-cll-correlates-with-3-disease-characteristics","status":"publish","type":"post","link":"https:\/\/clladvocates.nz\/?p=13034","title":{"rendered":"COVID-19 Severity in CLL Correlates With 3 Disease Characteristics"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”3″ bottom_padding=”3″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″][vc_column column_width_percent=”100″ gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″][vc_custom_heading heading_semantic=”h1″ text_size=”h1″]<\/p>\n

COVID-19 Severity in CLL Correlates With 3 Disease Characteristics<\/h1>\n

[\/vc_custom_heading][vc_column_text]This article was originally published by Targeted Oncology<\/a><\/p>\n

The severity of coronavirus disease 2019 (COVID-19) increases with age in patients with chronic lymphocytic leukemia (CLL). However, age and the existence of comorbidities may not impact death from COVID-19, according to results from a retrospective international study published in\u00a0Leukemia<\/em>.<\/p>\n

The study was conducted through a collaboration between the European Research Initiative on CLL (ERIC) and CLL Campus. Study results came from a survey completed by 121 investigators at 118 sites around the world. Of the survey responder, 58 investigators confirmed that there were COVID-19 cases in their CLL cohort. The majority of the cases were identified in Europe (74%), followed by Asia (13.6%), Latin America (4.2%), Africa (3.4%), Canada (2.5%), and Australia (1.7%). Altogether, 156 cases of COVID-19 in patients with CLL were reported from a pool of 15,083 patients. COVID-19 cases were symptomatic and required hospitalization in 141 patients. Preventative measures for SARS-CoV-2 were reported by all but 0.8% of the sites.<\/p>\n

\u201cTo the best of our knowledge, we present here the largest European series of patients with CLL infected by SARS-CoV-2 and experiencing COVID-19. Among the European cases (96.8% of the total) included in this project, almost 90% originated from Italy and Spain, hence mirroring the dynamics of the SARS-CoV-2 pandemic in Europe with Italy being the first country in a number of infected individuals followed by Spain, with a lower incidence,\u201d wrote the study authors led by Paolo Ghia, MD, PhD of the Universit\u00e0 Vita-Salute San Raffaele.<\/p>\n

\n

To continue reading this article here on Targeted Oncology<\/a><\/p>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

The severity of coronavirus disease 2019 increases with age in patients with chronic lymphocytic leukemia. However, age and the existence of comorbidities may not impact death from COVID-19, according to results from a retrospective international study.<\/p>\n","protected":false},"author":1,"featured_media":13038,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17,22,23],"tags":[],"class_list":["post-13034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured","category-covid19","category-research"],"jetpack_featured_media_url":"https:\/\/clladvocates.nz\/wp-content\/uploads\/2020\/08\/COVID-19-and-CLL.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/13034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13034"}],"version-history":[{"count":1,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/13034\/revisions"}],"predecessor-version":[{"id":13039,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/posts\/13034\/revisions\/13039"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=\/wp\/v2\/media\/13038"}],"wp:attachment":[{"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clladvocates.nz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}